LONDON: The coronavirus has ravaged the homes of the elderly in the UK, as in the United States, and has caused tens of thousands of lives. Now the UK expects it to be changing, thanks to a self-produced vaccine that has not yet been licensed anywhere else in the West.
More than four million people at highest risk in the UK, almost 8% of the adult population, have been vaccinated with at least one vaccine.
Among them is more than half of the most fragile group of all: the 300,000 elderly residents in nursing homes who can’t travel to shoot themselves. The key to getting there has been the mobile vaccination teams armed with a shot developed by Oxford University and AstraZeneca PLC.
Along with a network of GPs and vaccination centers in sports centers, hotels and cathedrals, this feature has helped the country follow the path to the goal of vaccinating its 15 million most vulnerable people by mid-February.
The government says the AstraZeneca vaccine, which has also been licensed in India, Morocco and some Latin American countries, has changed the game when it comes to hiding people in nursing homes more small.